Researcher Talks: Christine Harrison on childhood leukaemia

10 Oct 2017

Christine Harrison describes new treatments in development which target leukaemia cells to give children with leukaemia a better quality of life

Christine is Professor of Childhood Cancer Cytogenetics at Newcastle University and is a member of our Research Funding Committee. She speaks about childhood leukaemia at our Grantholders' Day in 2016.

“My work involves the study of leukaemia in children. Going back to when my research was first funded, and even further back to 1960 when Bloodwise first came on the scene, there was no effective treatment for these children. But now, in current treatment trials, 9 out of 10 of children with leukaemia will survive.

This success story does still come with a price because the drugs that are given to these children are nasty – they're poisons. So my current research is working on the genetics and what what's happening inside the cell to develop new treatments which target specifically the leukaemia cells without harming the normal cells to give children with leukaemia a much better quality of life.

The long term [aim] is to really cut the long term side effects that that these children have. So I would just like to say thank you very much to Bloodwise for the long-term funding of my research and for enabling all of these great successes along the way. Thank you very much to to all of the fundraisers without whom they would this research would not have been possible into improving lives for people with blood cancers.”

Read our information and support on childhood leukaemia.